NO971029L - Fremgangsmåter for hemming av endometriale metoser - Google Patents
Fremgangsmåter for hemming av endometriale metoserInfo
- Publication number
- NO971029L NO971029L NO971029A NO971029A NO971029L NO 971029 L NO971029 L NO 971029L NO 971029 A NO971029 A NO 971029A NO 971029 A NO971029 A NO 971029A NO 971029 L NO971029 L NO 971029L
- Authority
- NO
- Norway
- Prior art keywords
- metoses
- methods
- inhibiting endometrial
- inhibiting
- endometrial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/310,292 US5843964A (en) | 1994-09-22 | 1994-09-22 | Methods of inhibiting endometrial mitoses |
PCT/US1995/011926 WO1996009050A1 (en) | 1994-09-22 | 1995-09-20 | Methods of inhibiting endometrial mitoses |
Publications (2)
Publication Number | Publication Date |
---|---|
NO971029D0 NO971029D0 (no) | 1997-03-06 |
NO971029L true NO971029L (no) | 1997-03-06 |
Family
ID=23201835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971029A NO971029L (no) | 1994-09-22 | 1997-03-06 | Fremgangsmåter for hemming av endometriale metoser |
Country Status (16)
Country | Link |
---|---|
US (1) | US5843964A (ko) |
EP (1) | EP0782446A4 (ko) |
JP (1) | JPH10506108A (ko) |
KR (1) | KR970706000A (ko) |
CN (1) | CN1158086A (ko) |
AU (1) | AU692309B2 (ko) |
CA (1) | CA2200451A1 (ko) |
CZ (1) | CZ83997A3 (ko) |
FI (1) | FI971197A0 (ko) |
HU (1) | HUT76828A (ko) |
IL (1) | IL115383A0 (ko) |
MX (1) | MX9702148A (ko) |
NO (1) | NO971029L (ko) |
NZ (1) | NZ294123A (ko) |
WO (1) | WO1996009050A1 (ko) |
ZA (1) | ZA957949B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0777476A4 (en) * | 1994-08-22 | 1999-06-23 | Lilly Co Eli | METHODS FOR PREVENTING UTERUS CANCER |
ES2246234T3 (es) | 1999-05-04 | 2006-02-16 | Strakan International Limited | Glicosidos de androgenos y actividad androgenica de los mismos. |
USD692738S1 (en) | 2011-06-30 | 2013-11-05 | Hellermanntyton Corporation | Cable tie tensioning and cut-off tool |
PL2726229T3 (pl) | 2011-06-30 | 2016-11-30 | Narzędzie do napinania i odcinania opasek kablowych | |
EP3230167B1 (en) | 2014-12-12 | 2020-03-25 | Hellermanntyton Corporation | Compound tension and calibration mechanism for cable tie tensioning and cut-off tool |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
US5461065A (en) * | 1993-10-15 | 1995-10-24 | Eli Lilly And Company | Methods for inhibiting endometriosis |
WO1996005832A1 (en) * | 1994-08-22 | 1996-02-29 | Eli Lilly And Company | Methods of inhibiting primary endometrial hyperplasia |
-
1994
- 1994-09-22 US US08/310,292 patent/US5843964A/en not_active Expired - Fee Related
-
1995
- 1995-09-20 HU HU9701280A patent/HUT76828A/hu unknown
- 1995-09-20 NZ NZ294123A patent/NZ294123A/en unknown
- 1995-09-20 AU AU36788/95A patent/AU692309B2/en not_active Ceased
- 1995-09-20 CZ CZ97839A patent/CZ83997A3/cs unknown
- 1995-09-20 CN CN95195172A patent/CN1158086A/zh active Pending
- 1995-09-20 ZA ZA957949A patent/ZA957949B/xx unknown
- 1995-09-20 CA CA002200451A patent/CA2200451A1/en not_active Abandoned
- 1995-09-20 KR KR1019970701826A patent/KR970706000A/ko not_active Application Discontinuation
- 1995-09-20 WO PCT/US1995/011926 patent/WO1996009050A1/en not_active Application Discontinuation
- 1995-09-20 EP EP95934455A patent/EP0782446A4/en not_active Withdrawn
- 1995-09-20 MX MX9702148A patent/MX9702148A/es unknown
- 1995-09-20 JP JP8511041A patent/JPH10506108A/ja active Pending
- 1995-09-21 IL IL11538395A patent/IL115383A0/xx unknown
-
1997
- 1997-03-06 NO NO971029A patent/NO971029L/no unknown
- 1997-03-21 FI FI971197A patent/FI971197A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
US5843964A (en) | 1998-12-01 |
AU692309B2 (en) | 1998-06-04 |
HUT76828A (en) | 1997-11-28 |
JPH10506108A (ja) | 1998-06-16 |
EP0782446A4 (en) | 1999-01-07 |
KR970706000A (ko) | 1997-11-03 |
CA2200451A1 (en) | 1996-03-28 |
IL115383A0 (en) | 1995-12-31 |
CN1158086A (zh) | 1997-08-27 |
FI971197A (fi) | 1997-03-21 |
ZA957949B (en) | 1997-03-20 |
FI971197A0 (fi) | 1997-03-21 |
NO971029D0 (no) | 1997-03-06 |
AU3678895A (en) | 1996-04-09 |
NZ294123A (en) | 1999-09-29 |
CZ83997A3 (en) | 1997-07-16 |
EP0782446A1 (en) | 1997-07-09 |
WO1996009050A1 (en) | 1996-03-28 |
MX9702148A (es) | 1997-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971520L (no) | Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y | |
NO973635L (no) | Fremgangsmåte for hemming av celle-celle adhesjon | |
NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
DK0652005T3 (da) | Fremgangsmåder til inhibering af endometriose | |
NO944919L (no) | Fremgangsmåte for å inhibere atrofi av huden eller vagina | |
NO944927L (no) | Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom | |
MX9701329A (es) | Metodos para la inhibicion de la replicacion viral. | |
MX9701325A (es) | Metodos para inhibir la mucositis ulcerativa. | |
MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
DK0659417T3 (da) | Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen | |
NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
NO944924L (no) | Fremgangsmåter for inhibering av Turner's syndrom | |
NO970786L (no) | Fremgangsmåte for hemming av benprotesedegradering | |
NO944917D0 (no) | Anvendelse av 2-fenyl-3-aroyltiofener for inhibering av eggstokkdysgenese, forsinket pubertet eller seksuell infantilisme | |
NO975580L (no) | Fremgangsmåte for å inhibere melanom | |
NO971029L (no) | Fremgangsmåter for hemming av endometriale metoser | |
EA199700136A1 (ru) | Способы ингибирования экзогенных эстрогенов | |
NO981578L (no) | FremgangsmÕte for hemming av plasminogenaktivatorhemmer I | |
NO973609L (no) | Fremgangsmåte for å inhibere effektene av IL-6 | |
NO971794L (no) | Fremgangsmåte for hemming av tilstander forbundet med bradykinin | |
NO970783L (no) | Fremgangsmåte for å hindre endometrialkreft | |
MX9701333A (es) | Metodos para inhibir el daño neuronal. | |
NO20000750L (no) | FremgangsmÕte for Õ redusere blodplatetall | |
NO944909L (no) | Fremgangsmåter for inhibering av mannlig infertilitet | |
NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter |